The Battle For The White House Is Not Over Yet.

Yesterday, President Donald Trump appeared before the media and still does not recognize the results, while Joe Biden’s cabinet officials are being avoided in offices where they should be making a handover for a smooth transition. Nevertheless, the hope of a possible new vaccine release, has boosted the market and moved some of the major U.S. stock market indices upwards at the end of the week: the DJI had a weekly increase of 4% and the S&P 500 of 2.1%, in contrast, the Nasdaq 100 fell by 1.3% (after growing 8.6% the previous week).

Optimism was heightened by Biden’s statement that he does not plan to make any national shutdowns during his administration but will promote localized and rapid restrictions to stop the virus. In addition, he informed that his cabinet will meet this week with some pharma companies that are developing the vaccine against COVID-19, as one of his main priorities is to stop the spread of the virus. Therefore, he will begin negotiations with Pfizer this week - if they reach an agreement, this would mean that the US government could buy millions of doses for the Americans, a multi-million dollar deal for the company. We must be very attentive then to what they agree since this could mean a lot for Pfizer’s shares that on Friday closed with an increase of 3% and one weekly of 6%. The Fight Between Google and the U.S. Department of Justice Continues

After failing to reach a settlement following the antitrust suit that presides over these negotiations, the U.S. offered Google access to a third-party protective order, but the mega-capitalization behemoth refused and, at the same time, pressured its lawyers to prepare an effective defense by accessing confidential data that supports the legal action - information that the government does not want to give them, of course.

Other companies involved in the lawsuit, such as Oracle, AT&T and Amazon will also have to negotiate with the Department of Justice this Friday - we will see whether or not they join their requests. For now, Google will have to prove that its competitive policies do not violate the law in order to free itself from the biggest monopolization and control scandal it has ever faced. **Pfizer and BioNTech: To the Stars and Beyond **🚀💫

The vaccine developed by these companies is proving to be increasingly safe, thanks to the fact that they have reached 90% effectiveness in trials. I can only say that the problem now seems to be how to manage its preservation and refrigeration since the specialized freezers required by the vaccine are too expensive and there are very limited supplies to meet the demand.

Meanwhile, Moderna Inc. will soon publish the results of its clinical trials. Given that this vaccine requires less refrigeration, investors may show more interest in it if it finds significant effectiveness.